Literature DB >> 6616433

Translocation (6;9)(p23;q34) in acute nonlymphocytic leukemia.

S Schwartz, R Jiji, S Kerman, J Meekins, M M Cohen.   

Abstract

A consistent chromosomal abnormality t(6;9)(p23;q34) was demonstrated in the bone marrow or unstimulated peripheral blood cultures of two patients with acute nonlymphocytic leukemia (ANLL). Only two additional cases with ANLL and a similar cytogenetic finding have been reported, indicating that this translocation may represent another chromosomal abnormality specifically associated with ANLL.

Entities:  

Mesh：

Year:  1983        PMID： 6616433     DOI： 10.1016/0165-4608(83)90116-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  6 in total

Review 1.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

Review 2.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

3.  Basophils in acute myeloid leukaemia.

Authors:  C F Hoyle; P D Sherrington; P Fischer; F G Hayhoe
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

4.  Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Todd A Alonzo; Pilar Palomo Moraleda; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Yaddanapudi Ravindranath; Beverly Lange; William G Woods; Alan S Gamis; Soheil Meshinchi
Journal:  Br J Haematol       Date:  2014-03-25       Impact factor: 6.998

5.  Genetic change in the cancer cell.

Authors:  D G Harnden
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

6.  A novel variant translocation (1;9)(p22;q34) resulting in a DEK/NUP214 fusion gene in a patient with acute myeloid leukemia: A case report.

Authors:  Qishan Hao; Qi Zhang; Chengwen Li; Shuning Wei; Qinghua Li; Yang Song; Yingchang Mi
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.